Nurse Anesthetist - CR in Ellsworth, ME Accepting Medicare

5 Nurse Anesthetist - CR nurses found. Showing 1 - 5

Elizabeth Mccann, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 50 Union Street, Ellsworth, ME 04605 Phone: 207-664-5304    Fax: 207-664-5305

Ewell Nichols Jr., CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 50 Union Street, Ellsworth, ME 04605 Phone: 207-664-5304    Fax: 207-664-5305

Enid M. Cox, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 50 Union St, Maine Coast Memorial Hospital, Ellsworth, ME 04605 Phone: 207-664-5304    Fax: 207-664-5305

Mr. James Howard Mackey Iii, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 50 Union St, Ellsworth, ME 04605 Phone: 207-664-5311    Fax: 207-664-5305

Mary Elizabeth Talley, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 50 Union St, Maine Coast Memorial Hospital, Ellsworth, ME 04605 Phone: 207-664-5304    Fax: 207-664-5305

News Archive

RainDance Technologies closes $16.5 million Series E financing round

RainDance Technologies, Inc., an innovative genomics tools company making molecular testing of complex diseases more standardized and readily available, today announced that it has closed a $16.5 million Series E financing round extension. New investors include GE Ventures and Northgate Capital; all existing financial investors also participated in this round of financing.

New combination technique improves study of protein characterization

Using a combination of high-powered computers and advanced experimental magnetic resonance data, a Florida State University biophysical chemist has developed techniques that improve the way scientists can study and predict the structure and dynamics of proteins found in the human body. His innovations could ultimately shorten the time it takes researchers to develop new, more effective drugs and better understand biomedical processes that underlie a variety of health conditions.

EpiCept first quarter net loss decreases to $2.5 million

EpiCept Corporation today announced operating and financial results for the three months ended March 31, 2011, and provided an update with respect to the Company's key business initiatives.

Rich Plasma and Stem Cell therapies improve orthopedic conditions

Although stem cells sounds innovative and cutting edge, this therapy has been around for quite some time. In today's advanced medical climate stem cells are being used to treat many orthopedic conditions including osteoarthritis of the hip knee and shoulder, partial tears of tendons, muscles, and ligaments including rotator cuff tears, and various back conditions including disc herniations.

Read more Medical News

› Verified 6 days ago